Other names: MDS
A group of disorders characterised by low white blood cell counts, low platelet counts, and, in some cases, increased monocytes. The primary problem is in the bone marrow cellularity.
Other names: MDS
A group of disorders characterised by low white blood cell counts, low platelet counts, and, in some cases, increased monocytes. The primary problem is in the bone marrow cellularity.
| Name | Drug Class | Updated |
|---|---|---|
| Filgrastim | Colony stimulating factors | 14-Aug-2023 |
| Luspatercept | Miscellaneous erythropoiesis agents | 13-Aug-2023 |
| Decitabine | Antimetabolites | 11-Aug-2023 |
| Cedazuridine and decitabine | Antineoplastic combinations | 11-Aug-2023 |
| Azacitidine | Miscellaneous antineoplastics | 11-Aug-2023 |
| Vidaza | Miscellaneous antineoplastics | 14-Jul-2023 |
| Reblozyl | Miscellaneous erythropoiesis agents | 14-Jul-2023 |
| Inqovi | Antineoplastic combinations | 13-Jul-2023 |
| Dacogen | Antimetabolites | 13-Jul-2023 |